While EP3 has been demonstrated to exert an inhibitory influence on GSIS, increasing evidence suggests that the impact of EP3 may manifest primarily when β-cell dysfunction is already established, as observed in T2DM (Carboneau et al., 2017; Truchan et al., 2021). The gene discussed is PTGER3; the disease is type 2 diabetes mellitus.